Charles River Laboratories International, Inc. (CRL) Revenue by Year

CRL

Charles River Laboratories International, Inc. generated $4.0B in revenue in fiscal year 2025. This represents a decrease of 0.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $4.0B in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Charles River Laboratories International, Inc. has filed alongside them.

FY2025 annual

Revenue $4.0B

YoY -0.9%

5Y CAGR +6.5%

10Y CAGR +11.4%

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 27, 2026 Reported Aug 5, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRL Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$4.0B	$4.0B-0.9%	$4.0B-1.9%	$4.1B+3.9%	$4.0B+12.3%	$3.5B+21.1%	$2.9B+11.5%	$2.6B+15.7%	$2.3B+22.0%	$1.9B+10.5%	$1.7B+23.3%	$1.4B+5.1%	$1.3B+11.3%	$1.2B+3.2%	$1.1B-1.1%	$1.1B

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

CRL Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Revenue	$1.0B-2.7%	$995.8M+1.2%	$994.2M-0.8%	$1.0B-0.5%	$1.0B+0.6%	$984.2M-2.7%	$1.0B-1.1%	$1.0B-1.6%	$1.0B-0.3%	$1.0B	$1.0B-7.9%	$1.0B+3.8%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Charles River Laboratories International, Inc. financials

Frequently Asked Questions

What was Charles River Laboratories International, Inc.'s revenue in fiscal year 2025?

Charles River Laboratories International, Inc. generated $4.0B in revenue in fiscal year 2025.

How fast is Charles River Laboratories International, Inc.'s revenue growing?

Charles River Laboratories International, Inc. (CRL) revenue fell by 0.9% year over year, from $4.0B to $4.0B in fiscal year 2025.

What is Charles River Laboratories International, Inc.'s revenue over the last twelve months?

Charles River Laboratories International, Inc. (CRL) reported $4.0B in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

How has Charles River Laboratories International, Inc.'s revenue changed over the years?

Across the 15 fiscal years this page covers, Charles River Laboratories International, Inc. (CRL) revenue went from $1.1B in fiscal year 2011 to $4.0B in fiscal year 2025.

What was Charles River Laboratories International, Inc.'s revenue in the most recent quarter?

Charles River Laboratories International, Inc. (CRL) reported $1.0B in revenue in Q2 2026. This represents a decrease of 2.7% from the same quarter a year earlier.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Charles River Laboratories International, Inc. (CRL) reported on that line in every period on record.